Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
57.55
+0.40 (0.70%)
May 22, 2026, 1:32 PM EDT - Market open

Boston Scientific Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Net Income
1,339-755733.5672-469322493-50427031414018826011095419186
Depreciation & Amortization
351365342336325348306311304313300298285294284284274290272263
Stock-Based Compensation
8371797574696866635959605555585552495147
Other Adjustments
-5103249-17514899-51854699101460-3824665.518780-65-132.5
Change in Receivables
-117-98-32-32-107-90-33-114-114-74-3-75-86-44-14-96-66-14814-28
Changes in Inventories
-177-50-9465-10946-55-95-124-59-202-214-185-46-95-72-108-31-21515
Changes in Accounts Payable
-512285165231-38538523771-4502317289-211335-141-81-368133-65333
Changes in Other Operating Activities
-109185-31-77-1717-71-555312-14-4189-54-104-1401155-72
Operating Cash Flow
3481,3641,3431,2865411,4561,002813164957698658190807470307-58478465643
Operating Cash Flow Growth
-35.68%-6.32%34.03%58.18%229.88%52.14%43.55%23.56%-13.68%18.59%48.51%114.33%-68.83%1.07%-52.25%--28.98%-27.68%139.03%
Capital Expenditures
-177-351-181-157-187-277-179-155-179-267-190-143-111-212-150-105-121-266-107-106
Sale of Property, Plant & Equipment
----------1032118433
Purchases of Investments
61-74-70-33-77-16-125-73-66--16-63-10-------
Proceeds from Sale of Investments
---------------210-10018767
Payments for Business Acquisitions
-523-89-256-1,009-239-3,418-1,127-48-47-7930-643-3750-710-1,471-244-1,3080
Proceeds from Business Divestments
-----------------2500
Other Investing Activities
48-438.53-557-78916184519201928.5
Investing Cash Flow
-591-512-502-1,126-500-3,704-1,427-271-285-1,053-197-840-484-183-225-29-1,574-461-1,2070
Short-Term Debt Repaid
-259--12-500-1,083-00-504----000-250---
Net Short-Term Debt Issued (Repaid)
-259--12-500-1,083-00-504----000-250---
Long-Term Debt Issued
-0001,5580002,145----00-13,271---
Long-Term Debt Repaid
-------------000-3,184---
Net Long-Term Debt Issued (Repaid)
-0001,5580002,145----00-187---
Issuance of Common Stock
81-11532115-962680-752763-59652-6420
Repurchase of Common Stock
-85-3-5-5-118-4-3-2-78-2-2-2-50-4-2-1-46-2-1-1
Net Common Stock Issued (Repurchased)
-4-311027-3-493242-2732513-45756-26319
Preferred Share Dividends Paid
----------0-14-14-13-14-14-14-13-14-14
Other Financing Activities
3-1,399-8-37.5-2380-86-7.5-744-5713.5-680-243-332164-1-43-3
Financing Cash Flow
-260-184-104-3402332147241,569151643-691-199-344-6-862
Effect of Exchange Rate Changes on Cash and Cash Equivalents
03-2239-96-1-74-5-3-3-6-6--1-31
Net Cash Flow
-504671735-179314-2,044-4125651,441-77513-143-36362939-71-1,6399-739645
Free Cash Flow
1711,0131,1621,1293541,179823658-1569050851579595320202-179212358537
Free Cash Flow Growth
-51.70%-14.08%41.19%71.58%-70.87%62.01%27.77%-15.97%58.75%154.95%-180.66%-10.62%-62.38%--58.76%-39.73%167.16%
FCF Margin
3.29%19.16%22.94%22.31%7.59%25.85%19.55%15.97%-0.39%18.52%14.40%14.31%2.33%18.35%10.09%6.23%-5.92%6.78%12.21%17.45%
Free Cash Flow Per Share
0.110.680.780.760.240.790.550.44-0.010.470.340.350.050.410.220.14-0.120.150.250.37
Levered Free Cash Flow
4589399807417161,0507953851,6325684424773758618167-529217345605
Unlevered Free Cash Flow
643.761,0571,0811,136335.841,133839.87459.6743.33645.84510.71541.78126.14603.14118.71240.78-131.42277.67275.72760.06
Updated May 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q